Cargando…

Small-animal PET evaluation of [(11)C]MC113 as a PET tracer for P-glycoprotein

Detalles Bibliográficos
Autores principales:	Mairinger, Severin, Colabufo, Nicola A, Wanek, Thomas, Kuntner, Claudia, Stanek, Johann, Erker, Thomas, Cantore, Mariangela, Berardi, Francesco, Perrone, Roberto, Müller, Markus, Langer, Oliver
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016558/ http://dx.doi.org/10.1186/1471-2210-10-S1-A46

Ejemplares similares

Assessing the Functional Redundancy between P-gp and BCRP in Controlling the Brain Distribution and Biliary Excretion of Dual Substrates with PET Imaging in Mice
por: Hernández-Lozano, Irene, et al.
Publicado: (2021)

Factors Governing P-Glycoprotein-Mediated Drug–Drug Interactions at the Blood–Brain Barrier Measured with Positron Emission Tomography
por: Wanek, Thomas, et al.
Publicado: (2015)

Inhibition of breast cancer resistance protein at the murine blood-brain barrier by Ko143 studied with [(11)C]tariquidar and PET
por: Wanek, Thomas, et al.
Publicado: (2011)

Use of PET Imaging to Assess the Efficacy of Thiethylperazine to Stimulate Cerebral MRP1 Transport Activity in Wild-Type and APP/PS1-21 Mice
por: Wölfl-Duchek, Michael, et al.
Publicado: (2022)

A PET microdosing study with the P-glycoprotein inhibitor tariquidar
por: Bauer, Martin, et al.
Publicado: (2012)

[(11)C]Elacridar as a novel P-glycoprotein PET tracer, assessment of whole-body distribution and radiation dosimetry in humans
por: Bauer, Martin, et al.
Publicado: (2011)

Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[(11)C]verapamil PET
por: Bauer, Martin, et al.
Publicado: (2010)

Characterization of an APP/tau rat model of Alzheimer’s disease by positron emission tomography and immunofluorescent labeling
por: Filip, Thomas, et al.
Publicado: (2021)

[(18)F]FE@SUPPY: a suitable PET tracer for the adenosine A3 receptor? An in vivo study in rodents
por: Haeusler, Daniela, et al.
Publicado: (2015)

Comparison of In Vitro Assays in Selecting Radiotracers for In Vivo P-Glycoprotein PET Imaging
por: Raaphorst, Renske M., et al.
Publicado: (2017)

Influence of Multidrug Resistance-Associated Proteins on the Excretion of the ABCC1 Imaging Probe 6-Bromo-7-[(11)C]Methylpurine in Mice
por: Zoufal, Viktoria, et al.
Publicado: (2018)

In Vivo Induction of P-Glycoprotein Function can be Measured with [(18)F]MC225 and PET
por: García-Varela, Lara, et al.
Publicado: (2021)

Authentically radiolabelled Mn(II) complexes as bimodal PET/MR tracers
por: Vanasschen, Christian, et al.
Publicado: (2015)

Crystallographic study of PET radiotracers in clinical evaluation for early diagnosis of Alzheimers
por: Altomare, Angela, et al.
Publicado: (2014)

In vivo characterization of [(18)F]AVT-011 as a radiotracer for PET imaging of multidrug resistance
por: Kannan, Pavitra, et al.
Publicado: (2019)

Influence of Cation Transporters (OCTs and MATEs) on the Renal and Hepatobiliary Disposition of [(11)C]Metoclopramide in Mice
por: Hernández-Lozano, Irene, et al.
Publicado: (2021)

Biocompatible branched copolymer nanoparticles prepared by RAFT polymerization as MRI/PET bimodal tracers
por: Yang, Chang-Tong, et al.
Publicado: (2015)

Evaluation of P-glycoprotein function at the blood–brain barrier using [(18)F]MC225-PET
por: Mossel, Pascalle, et al.
Publicado: (2021)

Update on PET Tracer Development for Muscarinic Acetylcholine Receptors
por: Ozenil, Marius, et al.
Publicado: (2021)

Comparison of fully-automated radiosyntheses of [(11)C]erlotinib for preclinical and clinical use starting from in target produced [(11)C]CO(2) or [(11)C]CH(4)
por: Philippe, Cécile, et al.
Publicado: (2018)

Automated synthesis, preclinical toxicity, and radiation dosimetry of [(18)F]MC225 for clinical use: a tracer for measuring P-glycoprotein function at the blood-brain barrier
por: Toyohara, Jun, et al.
Publicado: (2020)

Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model
por: Wanek, Thomas, et al.
Publicado: (2020)

Breast PET/MRI Hybrid Imaging and Targeted Tracers
por: Romeo, Valeria, et al.
Publicado: (2022)

Pharmacokinetic Modeling of [(18)F]MC225 for Quantification of the P-Glycoprotein Function at the Blood–Brain Barrier in Non-Human Primates with PET
por: García-Varela, Lara, et al.
Publicado: (2020)

BEZ235 impairs gastric cancer growth by inhibition of PI3K/mTOR in vitro and in vivo
por: Füreder, Thorsten, et al.
Publicado: (2010)

PET Tracers for Clinical Imaging of Breast Cancer
por: Peñuelas, Iván, et al.
Publicado: (2012)

Microfluidics for Synthesis of Peptide-Based PET Tracers
por: Liu, Yang, et al.
Publicado: (2013)

Advanced Tracers in PET Imaging of Cardiovascular Disease
por: Li, Yesen, et al.
Publicado: (2014)

Stroke detection with 3 different PET tracers
por: Dundar, Ayca, et al.
Publicado: (2019)

Emerging PET Tracers in Cardiac Molecular Imaging
por: Singh, Shashi Bhushan, et al.
Publicado: (2023)

Imidazoline-I2 PET Tracers in Neuroimaging
por: Parker, Christine A., et al.
Publicado: (2023)

Test–Retest Repeatability of [(18)F]MC225-PET in Rodents: A Tracer for Imaging of P-gp Function
por: García-Varela, Lara, et al.
Publicado: (2020)

Plasma radio-metabolite analysis of PET tracers for dynamic PET imaging: TLC and autoradiography
por: Li, Fiona, et al.
Publicado: (2020)

PET Imaging in Cardiac Sarcoidosis: A Narrative Review with Focus on Novel PET Tracers
por: Saric, Petar, et al.
Publicado: (2021)

Head-to-head comparison of (R)-[(11)C]verapamil and [(18)F]MC225 in non-human primates, tracers for measuring P-glycoprotein function
por: García-Varela, Lara, et al.
Publicado: (2021)

(R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood–brain barrier, and not by MRP1 and BCRP
por: Römermann, Kerstin, et al.
Publicado: (2013)

An innovative small molecule for promoting neuroreparative strategies
por: Colabufo, Nicola Antonio, et al.
Publicado: (2018)

Dedicated brain PET system of PET/MR for brain research
por: Cheng, Li, et al.
Publicado: (2015)

The potential of TOF PET-MRI for reducing artifacts in PET images
por: Iagaru, Andrei, et al.
Publicado: (2015)

Assess PET/MR in diagnosis of disease in comparison with PET/CT
por: Yan, Jianhua, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7q2kpqdtj8qf4l9vhetmgc0o14